Intranasal influenza vaccine based on virosomes

Details for Australian Patent Application No. 2007228736 (hide)

Owner Solvay Biologicals B.V.

Inventors Nauta, Jozef J.P.; Kersten, Alexander J.; Schoen, Pieter J.; Van Rheineck Leyssius, Dorine H.; Gerez, Lisya

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007228736

PCT Pub. Number WO2007/107585

Priority 60/784,462 22.03.06 US; 06111534.1 22.03.06 EP

Filing date 21 March 2007

Wipo publication date 27 September 2007

Acceptance publication date 15 December 2011

International Classifications

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/107585 Priority application(s): WO2007/107585

15 December 2011 Application Accepted

  Published as AU-B-2007228736

12 April 2012 Standard Patent Sealed

20 September 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Abbott Biologicals B.V. . Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007228741-FAD-2 mutants and high oleic plants

2007228716-Benzimidazoles which have activity at M1 receptor and their uses in medicine